News Highlights: Top Company News of the Day
30 November 2022 - 12:30AM
Dow Jones News
Rio Tinto Plans $600 Million Investment in Solar, Battery Storage for Australia's Pilbara
Rio Tinto said it intends to invest $600 million to build two
solar farms and battery storage in Australia's Pilbara region.
Horizon Therapeutics Fields Takeover Interest From Pharma Giants
The drugmaker recently had a market value almost $18 billion as
big pharmaceutical companies rely on acquisitions to expand
sales.
HPE's stock surges on record sales, strong revenue guidance
Hewlett Packard Enterprise Co.'s stock was initially up 7% in
extended trading Tuesday after the company reported quarterly
results in line with analyst estimates and offered strong revenue
guidance.
AMC Networks to Lay Off 20% of U.S. Workers as CEO Exits
The company has been under pressure from cord-cutting as
Americans have moved from traditional pay-TV packages to streaming
services. Shares of AMC closed 5.3% lower.
Twitter Under Elon Musk Abandons Covid-19 Misinformation Policy
The platform is an outlier among social-media companies in
giving up policing false and misleading information about
Covid-19.
BlockFi Affirms Efforts to Return Customer Funds
The cryptocurrency lender said in a bankruptcy-court hearing
that it is different from FTX and is working to return client funds
as soon as possible.
That Knee Surgery You Postponed Could Soon Hobble Insurance Giants
Managed care companies have outperformed the broader stock
market due to lower-than-expected medical costs, but that could
start to change in 2023.
Elon Musk's Apple Attack Sets Stage for Public Spat
The dispute could draw new attention to how speech is monitored
on the internet.
Apollo Taps Connecticut State Treasurer for New Client Role
Shawn Wooden, the state's public retirement plan investment
official, will become chief public pension strategist for Apollo
next year.
Nestlé Considers Shedding Peanut Allergy Treatment as Sales Disappoint
Palforzia, the world's only approved peanut allergy drug, has so
far proved a flop, potentially because of a laborious treatment
process.
(END) Dow Jones Newswires
November 29, 2022 19:15 ET (00:15 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.